DLTR
40
4
TXN
49
-6
RRC
60
-3
PCG
99
2
EXPE
96
-3
AES
41
2
SHW
70
2
GOOG
69
-10
FTI
78
-3
MRO
46
3
ETR
68
-3
FLR
48
3
REGN
42
-2
ABT
57
-5
LNC
45
-4
UA
57
4
EQT
57
-3
STX
52
-4
RCL
88
-2
GILD
56
-4
DLTR
40
4
TXN
49
-6
RRC
60
-3
PCG
99
2
EXPE
96
-3
AES
41
2
SHW
70
2
GOOG
69
-10
FTI
78
-3
MRO
46
3
ETR
68
-3
FLR
48
3
REGN
42
-2
ABT
57
-5
LNC
45
-4
UA
57
4
EQT
57
-3
STX
52
-4
RCL
88
-2
GILD
56
-4
Financhill
Back

Precision BioSciences Vs. Protagonist Therapeutics Industry Stock Comparison

Sell
12

DTIL
Precision BioSciences

Last Price:
7.70
Seasonality Move:
-6.51%
Sell
32

PTGX
Protagonist Therapeutics

Last Price:
41.02
Seasonality Move:
12.96%
Sell
12
Precision BioSciences (DTIL) is a Sell

Is Precision BioSciences a Buy, Sell or Hold?

  • The current Precision BioSciences [DTIL] share price is $8.08. The Score for DTIL is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • DTIL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
32
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $42.67. The Score for PTGX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DTIL Stock Price Chart

What is Precision BioSciences's stock price today?

  • The Precision BioSciences share price today is $8.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DTIL is experiencing selling pressure, which indicates risk of future bearish movement.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $42.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.

DTIL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 36.97 Sell
Chaikin Money Flow: -112838 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.28 - 8.88) Sell
Bollinger Bands (100): (8.68 - 10) Sell

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 35.81 Sell
Chaikin Money Flow: -366275 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.81 - 47.77) Sell
Bollinger Bands (100): (37.08 - 46.34) Buy

DTIL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.36 Sell
20-day SMA: 8.5 Sell
50-day SMA: 9.11 Sell
200-day SMA: 10.76 Sell
8-day EMA: 8.35 Sell
20-day EMA: 8.53 Sell
50-day EMA: 8.94 Sell
200-day EMA: 11.13 Sell

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.8 Sell
20-day SMA: 46.52 Sell
50-day SMA: 45.56 Sell
200-day SMA: 35.25 Buy
8-day EMA: 45.25 Sell
20-day EMA: 45.9 Sell
50-day EMA: 44.83 Sell
200-day EMA: 36.55 Buy

Precision BioSciences Earnings Growth & DTIL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $20.23 per share, and a decrease next year of $9.65 per share.

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.95 per share.

Precision BioSciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):